Endemic Cardiovascular Diseases of the Poorest Billion
- PMID: 27297348
- DOI: 10.1161/CIRCULATIONAHA.116.008731
Endemic Cardiovascular Diseases of the Poorest Billion
Abstract
The poorest billion people are distributed throughout the world, though most are concentrated in rural sub-Saharan Africa and South Asia. Cardiovascular disease (CVD) data can be sparse in low- and middle-income countries beyond urban centers. Despite this urban bias, CVD registries from the poorest countries have long revealed a predominance of nonatherosclerotic stroke, hypertensive heart disease, nonischemic and Chagas cardiomyopathies, rheumatic heart disease, and congenital heart anomalies, among others. Ischemic heart disease has been relatively uncommon. Here, we summarize what is known about the epidemiology of CVDs among the world's poorest people and evaluate the relevance of global targets for CVD control in this population. We assessed both primary data sources, and the 2013 Global Burden of Disease Study modeled estimates in the world's 16 poorest countries where 62% of the population are among the poorest billion. We found that ischemic heart disease accounted for only 12% of the combined CVD and congenital heart anomaly disability-adjusted life years (DALYs) in the poorest countries, compared with 51% of DALYs in high-income countries. We found that as little as 53% of the combined CVD and congenital heart anomaly burden (1629/3049 DALYs per 100 000) was attributed to behavioral or metabolic risk factors in the poorest countries (eg, in Niger, 82% of the population among the poorest billion) compared with 85% of the combined CVD and congenital heart anomaly burden (4439/5199 DALYs) in high-income countries. Further, of the combined CVD and congenital heart anomaly burden, 34% was accrued in people under age 30 years in the poorest countries, while only 3% is accrued under age 30 years in high-income countries. We conclude although the current global targets for noncommunicable disease and CVD control will help diminish premature CVD death in the poorest populations, they are not sufficient. Specifically, the current framework (1) excludes deaths of people <30 years of age and deaths attributable to congenital heart anomalies, and (2) emphasizes interventions to prevent and treat conditions attributed to behavioral and metabolic risks factors. We recommend a complementary strategy for the poorest populations that targets premature death at younger ages, addresses environmental and infectious risks, and introduces broader integrated health system interventions, including cardiac surgery for congenital and rheumatic heart disease.
Keywords: cardiomyopathies; cardiovascular diseases; congenital heart disease; epidemiology; global health; health equity; poverty; rheumatic heart disease.
© 2016 American Heart Association, Inc.
Similar articles
-
Cardiovascular disease burden attributable to dietary risk factors from 1990 to 2019: A systematic analysis of the Global Burden of Disease study.Nutr Metab Cardiovasc Dis. 2022 Apr;32(4):897-907. doi: 10.1016/j.numecd.2021.11.012. Epub 2021 Nov 29. Nutr Metab Cardiovasc Dis. 2022. PMID: 35067445
-
Burden of disease among the world's poorest billion people: An expert-informed secondary analysis of Global Burden of Disease estimates.PLoS One. 2021 Aug 16;16(8):e0253073. doi: 10.1371/journal.pone.0253073. eCollection 2021. PLoS One. 2021. PMID: 34398896 Free PMC article.
-
Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective.Glob Heart. 2020 Feb 12;15(1):15. doi: 10.5334/gh.403. Glob Heart. 2020. PMID: 32489788 Free PMC article. Review.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
The burden of disease among the global poor.Lancet. 1999 Aug 14;354(9178):586-9. doi: 10.1016/S0140-6736(99)02108-X. Lancet. 1999. PMID: 10470717
Cited by
-
Beneficial effects of time-restricted fasting on cardiovascular disease risk factors: a meta-analysis.BMC Cardiovasc Disord. 2024 Apr 16;24(1):210. doi: 10.1186/s12872-024-03863-6. BMC Cardiovasc Disord. 2024. PMID: 38627656 Free PMC article.
-
Spectrum of prevalent cardiovascular diseases in urban Port-au-Prince, Haiti: a population-based cross-sectional study.Lancet Reg Health Am. 2024 Apr 4;33:100729. doi: 10.1016/j.lana.2024.100729. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38590326 Free PMC article.
-
Self-reported cardiovascular disease risk factor screening among people living with HIV vs. members of the general population in Botswana: a community-based study.BMC Public Health. 2024 Jan 16;24(1):198. doi: 10.1186/s12889-024-17651-6. BMC Public Health. 2024. PMID: 38229024 Free PMC article.
-
Noncontact remote sensing of abnormal blood pressure using a deep neural network: a novel approach for hypertension screening.Quant Imaging Med Surg. 2023 Dec 1;13(12):8657-8668. doi: 10.21037/qims-23-970. Epub 2023 Oct 8. Quant Imaging Med Surg. 2023. PMID: 38106309 Free PMC article.
-
The Link between Overweight/Obesity and Noncommunicable Diseases in Ethiopia: Evidences from Nationwide WHO STEPS Survey 2015.Int J Hypertens. 2023 Nov 16;2023:2199853. doi: 10.1155/2023/2199853. eCollection 2023. Int J Hypertens. 2023. PMID: 38023617 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources